Related references
Note: Only part of the references are listed.Nonadherence to Oral Mercaptopurine and Risk of Relapse in Hispanic and Non-Hispanic White Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group
Smita Bhatia et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
Stephen P. Hunger et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Late MRD response determines relapse risk overall and in subsets of childhood T-cell ALL: results of the AIEOP-BFM-ALL 2000 study
Martin Schrappe et al.
BLOOD (2011)
Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Yousif Matloub et al.
BLOOD (2011)
History of treatment and long-term outcome of childhood acute lymphoblastic leukemia in Slovenia
S. Avcin et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2011)
History of treatment and long-term outcome in children with acute lymphoblastic leukaemia in Serbia
D. Micic et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2011)
Results of acute lymphoblastic leukemia treatment in children in the Slovak Republic
E. Kaiserova et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2011)
Long-term results in children with standard risk acute lymphoblastic leukaemia treated with 5.0 g/m2 versus 3.0 g/m2 methotrexate i.v. according to the modified ALL-BFM 90 protocol. The report of Polish paediatric Leukemia/lymphoma study group
K. Derwich et al.
MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2011)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter et al.
BLOOD (2010)
Detection of prognostically relevant genetic abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: recommendations from the Biology and Diagnosis Committee of the International Berlin-Frankfurt-Munster study group
Christine J. Harrison et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Clinical Outcome of Children With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005
Maurizio Arico et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Long-term results of treatment of childhood acute lymphoblastic leukemia in the Czech Republic
J. Stary et al.
LEUKEMIA (2010)
Long-term results of the Israeli National Studies in childhood acute lymphoblastic leukemia: INS 84, 89 and 98
B. Stark et al.
LEUKEMIA (2010)
Long-term results of five consecutive trials in childhood acute lymphoblastic leukemia performed by the ALL-BFM study group from 1981 to 2000
A. Moericke et al.
LEUKEMIA (2010)
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia
V. Conter et al.
LEUKEMIA (2010)
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: A Children's Oncology Group Report
P. S. Gaynon et al.
LEUKEMIA (2010)
Improved Early Event-Free Survival With Imatinib in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Children's Oncology Group Study
Kirk R. Schultz et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J. Borowitz et al.
BLOOD (2008)
Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival:: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95
Anja Moericke et al.
BLOOD (2008)
Long-term results of the AIEOP-ALL-95 trial for childhood acute lymphoblastic leukemia: Insight on the prognostic value of DNA index in the framework of Berlin-Frankfurt-Muenster-based chemotherapy
Maurizio Arico et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T. Flohr et al.
LEUKEMIA (2008)
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group
Nita L. Seibel et al.
BLOOD (2008)
A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial
Rob Pieters et al.
LANCET (2007)
Pulses of vincristine and dexamethasone in addition to intensive chemotherapy for children with intermediate-risk acute lymphoblastic leukaemia: a multicentre randomised trial
Valentino Conter et al.
LANCET (2007)
Interphase molecular cytogenetic screening for chromosomal abnormalities of prognostic significance in childhood acute lymphoblastic leukaemia: a UK Cancer Cytogenetics Group Study
CJ Harrison et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II
M Aricò et al.
BLOOD (2002)
Long-term results of three randomized trials (58831,58832,58881) in childhood acute lymphoblastic leukemia:: a CLCG-EORTC report
E Vilmer et al.
LEUKEMIA (2000)
Share Paper
